{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:43:09Z","timestamp":1761964989639,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.rvsc.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T12:30:11Z","timestamp":1525437011000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs"],"prefix":"10.1016","volume":"119","author":[{"given":"Asaka","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2018.04.015_bb0005","first-page":"1136","article-title":"Disappearance of pituitary macro adenoma with combination of ketoconazole and cabergoline treatment: an unusual case of Cushing's syndrome with interesting findings","volume":"10","author":"Ahmed","year":"2012","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5326\/0420269","article-title":"Long-term efficacy of trilostane administered twice daily in dogs with pituitary dependent hyperadrenocorticism","volume":"42","author":"Alenza","year":"2006","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0015","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mce.2007.11.024","article-title":"Somatostatin agonist for treatment of acromegaly","volume":"286","author":"Ben-Shlomo","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0025","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1751-0813.2003.tb12498.x","article-title":"Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism","volume":"81","author":"Braddock","year":"2003","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0030","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1210\/en.2008-0244","article-title":"Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine Cushing's disease","volume":"149","author":"de Bruin","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.rvsc.2018.04.015_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11154-008-9082-4","article-title":"Somatostatin and dopamine receptors as targets for medical treatment of Cushing's syndrome","volume":"10","author":"de Bruin","year":"2009","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","article-title":"SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile","volume":"146","author":"Bruns","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rvsc.2007.08.009","article-title":"Cushing's disease in dogs: Cabergoline treatment","volume":"85","author":"Castillo","year":"2008","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000327429","article-title":"Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease","volume":"94","author":"Castillo","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.rvsc.2018.04.015_bb0055","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0060","doi-asserted-by":"crossref","first-page":"R223","DOI":"10.1530\/JME-14-0011","article-title":"Somatostatin receptor ligands and resistance to treatment in pituitary adenomas","volume":"52","author":"Cuevas-Ramos","year":"2014","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0065","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/ERC-12-0191","article-title":"New developments in the medical treatment of Cushing's syndrome","volume":"19","author":"van der Pas","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.rvsc.2018.04.015_bb0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0075","series-title":"Canine and Feline Endocrinology","first-page":"379","article-title":"Canine hyperadrenocorticism","author":"Feldman","year":"2015"},{"key":"10.1016\/j.rvsc.2018.04.015_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/jvim.12500","article-title":"Serum cortisol concentrations in dogs with pituitary-dependent hyperadrenocorticism and atypical hyperadrenocorticism","volume":"29","author":"Frank","year":"2015","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","article-title":"Cabergoline monotherapy in the long-term treatment of Cushing's disease","volume":"163","author":"Godbout","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0195-5616(97)50028-3","article-title":"Diagnosis of canine hyperadrenocorticism","volume":"27","author":"Guptill","year":"1997","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1939-1676.2005.tb02747.x","article-title":"Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism","volume":"19","author":"Hanson","year":"2005","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1292\/jvms.09-0367","article-title":"Efficacy of transsphenoidal surgery on endocrinological status and serum chemistry parameters in dogs with Cushing's disease","volume":"72","author":"Hara","year":"2010","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/joe.0.1520387","article-title":"Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism","volume":"152","author":"Kooistra","year":"1997","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0110","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1532-950X.2014.12146.x","article-title":"Transsphenoidal surgery using a high definition video telescope for pituitary adenomas in dogs with pituitary dependent hypercortisolism: methods and results","volume":"43","author":"Mamelak","year":"2014","journal-title":"Vet. Surg."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/TCRM.S12952","article-title":"Treatment of Cushing disease: overview and recent findings","volume":"6","author":"Mancini","year":"2010","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1532-950X.1997.tb01502.x","article-title":"Transsphenoidal hypophysectomy in beagle dogs: evaluation of a microsurgical technique","volume":"26","author":"Meij","year":"1997","journal-title":"Vet. Surg."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1532-950X.1998.tb00123.x","article-title":"Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticism","volume":"27","author":"Meij","year":"1998","journal-title":"Vet. Surg."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2014.07.001","article-title":"Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo","volume":"394","author":"Murasawa","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/vr.150.26.799","article-title":"Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism","volume":"150","author":"Neiger","year":"2002","journal-title":"Vet. Rec."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/bbrc.1993.1412","article-title":"Multiple gene transcripts of the somatostatin receptor SSTR2: tissue active distribution and cAMp regulation","volume":"192","author":"Patel","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0150","first-page":"15","article-title":"Immunocytochemical study of the hypophysis in 25 dogs with pituitary-dependent hyperadrenocorticism","volume":"101","author":"Peterson","year":"1982","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0155","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1210\/jc.2003-030837","article-title":"Dopamine receptor expression and function in corticotroph pituitary tumors","volume":"89","author":"Pivonello","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ctsap.2007.02.003","article-title":"Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane","volume":"22","author":"Reine","year":"2007","journal-title":"Clin. Tech. Small. Anim. Pract."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1292\/jvms.71.93","article-title":"Coexistence of corticotroph adenoma and thyrotroph hyperplasia in a dog","volume":"71","author":"Teshima","year":"2009","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.rvsc.2018.04.015_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11102-009-0209-8","article-title":"Effectiveness of cabergoline in monotherapy and cobbined with ketoconazole in the management of Cushing's disease","volume":"13","author":"Vilar","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.rvsc.2018.04.015_bb0180","first-page":"717","article-title":"Epidemiological aspects of clinical hyperadrenocorticism in dogs (canine Cushing's syndrome)","volume":"18","author":"Willeberg","year":"1982","journal-title":"JAAHA"}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528817306355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528817306355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:08:09Z","timestamp":1758514089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528817306355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":36,"alternative-id":["S0034528817306355"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2018.04.015","relation":{},"ISSN":["0034-5288"],"issn-type":[{"type":"print","value":"0034-5288"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}